![{[setting('site_name')]}](https://www.flipnews.ca/uploads/setting/1694688257236407702.jpg)
- A study found that people using semaglutide-medications, such as Ozempic, for type 2 diabetes were less likely to seek medical treatment for tobacco use disorders.
- The potential-link-between-semaglutide and decreased substance use, including smoking, may be due to its effects on the brain's reward system.
- Further research is needed to understand the appropriate dosage and adverse effects of smoking cessation.
Popular Weight-Loss and Diabetes Medications Show Promise for Curbing Smoking, Study Suggests
Share
